No Data
No Data
No Data
No Data
No Data
Zhitong Hong Kong Shareholders' Rights Disclosure | April 16
Disclosure of Hong Kong Stock Shareholders' Rights | April 16
Zhitong FinanceApr 15 20:05 ET
Jacobson Pharma Raises HK$39 Million From Share Placement
Jacobson Pharma (HKG:2633) has completed the placement of 66 million shares to at least six investors at HK$0.60 apiece to raise net proceeds of around HK$38.8 million. The drugmaker will use the deal
MT NewswiresFeb 27 06:59 ET
Jacossen Pharmaceutical (02633) completed the placement of a total of 66 million shares
Jacochen Pharmaceutical (02633) issued an announcement. All conditions contained in the placement agreement have been met, and the placement has been completed on 20...
Zhitong FinanceFeb 27 03:37 ET
Jacobson Pharmaceuticals (02633.HK) plans to discount approximately 1.64% of the total placement of 66 million shares to raise approximately HK$38.8 million
Gelonghui, Feb. 19, 丨 Jacochen Pharmaceutical (02633.HK) announced that on February 19, 2024, the company signed a placement agreement with the placement agent. The company plans to place a total of 66 million shares, accounting for about 3.41% of the issued shares and about 3.30% of the issued share capital after the issuance was expanded. The placement price for each placed share is HK$0.60, which is approximately 1.64% off the closing price of HK$0.61 per share as reported on the date of the placement agreement. Assuming full distribution of the shares placed, the total proceeds from the placement would be approximately HK$39.6 million, and the net proceeds are expected to be around 3
Gelonghui FinanceFeb 19 08:33 ET
CICC: The pharmaceutical sector has entered the value investment range. It is recommended to focus on overseas exports and opportunities to increase the localization rate
CICC released a research report saying that after more than 2 years of systematic adjustments, the pharmaceutical sector has entered the value investment range.
Zhitong FinanceJan 29 19:11 ET
Zheshang Securities: What are the marginal changes and investment logic of the pharmaceutical sectors in 2023Q4?
The Zhitong Finance App learned that against the backdrop of high base figures for some products in the 2022 Q4 and 2023Q1 pharmaceutical sector, the bank is more optimistic about digesting undervaluation and investment opportunities with the logic of going overseas.
Zhitong FinanceJan 9 07:46 ET
No Data
No Data